mRNA |
parbendazole |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-07 |
mRNA |
KX2-391 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-07 |
mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
1e-07 |
mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
2e-07 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.2 |
2e-07 |
mRNA |
SB-743921 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
3e-07 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
3e-07 |
mRNA |
GW843682X |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
3e-07 |
mRNA |
FQI-2 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
3e-07 |
mRNA |
dinaciclib |
CTRPv2 |
pan-cancer |
AAC |
0.27 |
4e-07 |